# Short-term Dual Anti Platelet Therapy in Patients With ACS Treated With the COMBO Dual-therapy Stent

Study · id `cardio:ct-nct02118870` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02118870](<https://clinicaltrials.gov/study/NCT02118870>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT02118870

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1500 participants.

## Technical summary

Registry record NCT02118870. Randomized; no masking; primary purpose treatment. Start 2014-06-10 (actual); primary completion 2017-09 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 1500 participants (enrolled count; ClinicalTrials.gov record NCT02118870, source copy `cardio:ctgov-nct02118870-2019-02-08`, retrieved 2026-10-31)
- Started: 2014-06-10 (actual) (ClinicalTrials.gov record NCT02118870, source copy `cardio:ctgov-nct02118870-2019-02-08`, retrieved 2026-10-31)
- Primary completion: 2017-09 (actual) (ClinicalTrials.gov record NCT02118870, source copy `cardio:ctgov-nct02118870-2019-02-08`, retrieved 2026-10-31)
- Completion: 2018-09 (actual) (ClinicalTrials.gov record NCT02118870, source copy `cardio:ctgov-nct02118870-2019-02-08`, retrieved 2026-10-31)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02118870-2019-02-08`, retrieved 2026-10-31)

## The registry's words

- Brief title: Short-term Dual Anti Platelet Therapy in Patients With ACS Treated With the COMBO Dual-therapy Stent
- Acronym: REDUCE
- Condition: Acute Coronary Syndrome
- Intervention (Drug): Treatment 90 days DAPT
- Intervention (Drug): Treatment 360 days DAPT
- Lead sponsor: Diagram B.V.
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)

## Provenance

Content hash: c060b38ef8e25f861579d314a82cd954f5ef0d7f637a3485df6e7ce838563f85
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
